2-Substituted 4-, 5-, and 6-[(1 E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2 H)-ones and 2-substituted 4,5-bis[(1 E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2 H)-ones as potent platelet aggregation inhibitors: Design, synthesis, and SAR studies

Abstract

A set of regioisomeric 2-substituted pyridazin-3(2 H)-ones containing a 3-oxo-3-phenylprop-1-en-1-yl fragment at either position 4, 5 or 6 and 2-substituted pyridazin-3(2 H)-ones containing the same fragment both at positions 4 and 5 have been synthesized and evaluated as antiplatelet agents. The study allows the identification of a new highly potent platelet aggregation inhibitor ( 4c).